May 12, 2021
Novan Reports First Quarter 2021 Financial Results and Provides Corporate Update
– Topline efficacy results for ongoing Phase 3 study evaluating SB206 as a treatment for molluscum on track for targeted…
Pharmaceuticals, Biotechnology and Life Sciences
– Topline efficacy results for ongoing Phase 3 study evaluating SB206 as a treatment for molluscum on track for targeted…
Conference call and webcast today at 4:30pm Eastern/1:30pm PacificMENLO PARK, Calif., May 11, 2021 (GLOBE NEWSWIRE) — Talis Biomedical Corporation…
SANTA MONICA, Calif., May 11, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines…
MELBOURNE, Australia and ISTANBUL, Turkey, May 10, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today…
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…
-Firdapse® Q1 2021 Net Revenues of $30.2 Million -First Quarter 2021 GAAP Net Income of $7.7 Million; Non-GAAP Net Income…
– 58 subjects continue in the open-label extension study for TransCon PTH – COPENHAGEN, Denmark, May 10, 2021 (GLOBE NEWSWIRE)…
CANTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Organogenesis Holdings…
TORONTO, May 10, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a…
(Article 223-16 of General Regulation of the French financial markets authority)NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) — Listing market:…